AGL

Angle News - AGL

Stock Name Stock Symbol Market Stock Type
Angle Plc AGL London Ordinary Share
  Price Change Price Change % Stock Price Last Trade
0.00 0.0% 55.00 02:00:00
Open Price Low Price High Price Close Price Previous Close
55.00 55.00 55.00 55.00 55.00
more quote information »
Industry Sector
PHARMACEUTICALS & BIOTECHNOLOGY

Recent News

Date Time Source Heading
11/02/202214:17ALNCNewsTRADING UPDATES: Smithson assets grow; FireAngel delivers..
11/02/202202:01RNSNONAngle PLC Multiple downstream analysis techniques for CTCs
11/01/202211:41UKREGAngle PLC Second Price Monitoring Extn
11/01/202211:35UKREGAngle PLC Price Monitoring Extension
10/24/202208:35ALNCNewsIN BRIEF: Angle presents positive study results for..
10/24/202201:00RNSNONAngle PLC Parsortix poster presented at ISLB meeting
10/21/202212:15UKREGAngle PLC Issue of Equity
10/18/202216:04ALNCNewsTRADING UPDATES: essensys loss widens; Carclo demand strong
10/18/202201:00UKREGAngle PLC Streamlining of operations to increase cash runway
10/17/202208:23UKREGAngle PLC TR-1: Notification of major holdings
10/12/202208:39ALNCNewsTRADING UPDATES: Angus Energy exceeds monthly production..
10/12/202201:00RNSNONAngle PLC First regional distribution agreement
9/30/202211:30UKREGAngle PLC Holding(s) in Company
9/29/202214:30ALNCNewsEARNINGS SUMMARY: Angle revenue up; Synairgen, Bango loss..
9/29/202201:00UKREGAngle PLC Positive headline results from ovarian study
9/28/202216:10ALNCNewsTRADING UPDATES: Harmony Energy plans raise; Kavango sets..
9/28/202201:02RNSNONAngle PLC Study using Parsortix in head and neck cancer
9/13/202201:02RNSNONAngle PLC New poster presented at ASCP Meeting
9/12/202208:31ALNCNewsAngle notes Parsortix success in pelvic mass pilot study
9/12/202201:30RNSNONAngle PLC Novel assay predicts malignancy in pelvic mass
9/01/202201:02UKREGAngle PLC Notice of Interim Results and Webcast
7/28/202201:00RNSNONAngle PLC Novel insight into metastasis in NSCLC patients
7/20/202214:50ALNCNewsTRADING UPDATES: Angle hails study find; Eqtec buys plant in..
7/20/202208:33UKREGAngle PLC Holding(s) in Company
7/20/202201:00RNSNONAngle PLC NEW STUDY OF PARSORTIX SYSTEM IN NSCLC
7/19/202204:00UKREGAngle PLC Director/PDMR Shareholding
7/15/202208:45ALNCNewsIN BRIEF: Angle raises GBP20 million to progress Parsortix
7/15/202201:00UKREGAngle PLC Results of Capital Raise
7/14/202215:44ALNCNewsTRADING UPDATES: Shield closer to Canada approval; Angle..
7/14/202211:24UKREGAngle PLC Retail Offer via PrimaryBid
7/14/202211:23UKREGAngle PLC Proposed Placing and Retail Offer
7/08/202211:30UKREGAngle PLC Issue of Equity
6/29/202210:35UKREGAngle PLC Result of 2022 Annual General Meeting
6/27/202201:00RNSNONAngle PLC Spread of breast cancer accelerates during sleep
6/23/202212:24UKREGAngle PLC Issue of Equity
6/22/202204:01ALNCNewsAngle wins cancer monitoring contract for Parasortix system
6/22/202201:00UKREGAngle PLC Secured contract from pharma services customer
6/16/202210:55ALNCNewsTRADING UPDATES: Valereum opens NFT market; Conygar..
6/16/202201:00RNSNONAngle PLC Predicting immunotherapy response in SCLC
6/14/202214:13ALNCNewsIN BRIEF: Angle's Parsortix performs well on prostate cancer..
6/14/202201:00RNSNONAngle PLC Potential role of invasive cellular protrusions
5/30/202209:21ALNCNewsIN BRIEF: Angle partners with US urology group for..
5/30/202201:01UKREGAngle PLC Partnership with major United States urology group
5/27/202215:25ALNCNewsTRADING UPDATES: Savannah Energy to develop new projects in..
5/27/202201:01RNSNONAngle PLC Molecular characterisation of CTCs
5/25/202215:19ALNCNewsIN BRIEF: Angle shares rocket as Parasortix receives US FDA..
5/25/202210:35UKREGAngle PLC Price Monitoring Extension
5/25/202207:20DJNAngle's Parsortix System Gets U.S. Approval; Shares Jump
5/25/202206:30UKREGAngle PLC ANGLE receives FDA clearance for Parsortix
5/20/202203:48ALNCNewsIN BRIEF: Cancer study using Angle's Parasortix secures..
Your Recent History
LSE
AGL
Angle
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20221201 06:39:38